BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
51 hedge funds and large institutions have $17.2M invested in BRAINSTORM CELL THERAPUTC in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $3.72M | Put options by funds: $3.41M
0.29% more ownership
Funds ownership: 0.61% → 0.9% (+0.29%)
Holders
51
Holding in Top 10
–
Calls
$3.72M
Puts
$3.41M
Top Buyers
| 1 | +$2.06M | |
| 2 | +$1.13M | |
| 3 | +$1.01M | |
| 4 |
Millennium Management
New York
|
+$919K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$603K |
Top Sellers
| 1 | -$280K | |
| 2 | -$193K | |
| 3 | -$88K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$52K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$50K |